Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR) . EORTC Leukemia Cooperative Group (LCG) and GIMEMA
Suciu, S.; Solbu, G.; Zittoun, R.; Hayat, M.; Willemze, R.; de Witte, T.; Mandelli, F.
Bone Marrow Transplantation 7(Suppl 2): 34
1991
ISSN/ISBN: 0268-3369 PMID: 1878707 Document Number: 375874
Document emailed within 1 workday
Related Documents
Zittoun, R.; Mandelli, F.; Willemze, R.; de Witte, T.; Tura, S.; Ferrini, P.R.; Stryckmans, P.; Gattringer, C.; Petti, M.C.; Solbu, G. 1992: Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase IIi trial (AML8 A). the EORTC Leukemia Cooperative Group and the GIMEMA Group Leukemia 6(Suppl 2): 114-115Rowe, J.M.; Andersen, J.W.; Cassileth, P.A.; Oken, M.M.; Bennett, J.M.; Wiernik, P.H. 1992: Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience Leukemia 6(Suppl 4): 75-77
Jakse, G. 1989: Intravesical instillation of BCG in carcinoma in situ of the urinary bladder. EORTC protocol 30861. EORTC-GU Group Progress in Clinical and Biological Research 310: 187-192
Speletas, M.; Ritis, K.; Bourikas, G. 1996: Achievement and maintenance of complete remission in a patient with acute myelogenous leukemia after weekly administration of interleukin-2 Haematologica 81(4): 346-348
De Fabritiis, P.; Ferrero, D.; Sandrelli, A.; Tarella, C.; Meloni, G.; Pulsoni, A.; Pregno, P.; Badoni, R.; De Felice, L.; Gallo, E. 1989: Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission Bone Marrow Transplantation 4(6): 669-674
Miggiano, M.C.; Gherlinzoni, F.; Rosti, G.; Bandini, G.; Visani, G.; Fiacchini, M.; Ricci, P.; Testoni, N.; Motta, M.R.; Geromin, A.; Rizzi, S.; Belardinelli, A.; Mangianti, S.; Manfroi, S.; Tura, S. 1996: Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia Leukemia 10(3): 402-409
Gerhartz, H.H.; Visani, G.; Delmer, A.; Zwierzina, H.; Ribeiro, M.; Jacobs, A.; Marcus, R.; Baumelou, M.; Fière, D.; Labar, B. 1989: Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group Bone Marrow Transplantation 4(Suppl 3): 36-37
Anderlini, P.; Ghaddar, H.M.; Smith, T.L.; Pierce, S.; Kantarjian, H.M.; O'Brien, S.; Keating, M.J.; Freireich, E.J.; Estey, E.H. 1996: Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first Leukemia 10(6): 964-969
Saito, M.; Ino, T.; Shigemura, H.; Shimizu, S.; Matsui, T.; Ono, Y.; Nakamura, K.; Okamoto, M.; Takada, T.; Imura, H. 1985: Clinical evaluation of cases of remission induction failure in acute myelogenous leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(3 Part 1): 554-560
Odajima, H.; Iwatake, K.; Baba, M.; Ode, S.; Kawai, H.; Matsui, T. 1988: A case of complete remission following recurrent relapses 12 years after onset of acute myelocytic leukemia. Response to protocol including neocarzinostatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(1): 167-170
Alsabti, E.A.; Taleb, A.M.; Raji, H.M.; Kalil, O.Z.; Saleh, K.A. 1979: Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia Japanese Journal of Experimental Medicine 49(3): 157-168
Sievers, E.L.; Lange, B.J.; Sondel, P.M.; Krailo, M.D.; Gan, J.; Tjoa, T.; Liu-Mares, W.; Feig, S.A. 2000: Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia Cancer Journal from Scientific American 6(Suppl): S39-S44
van Breukelen, F.J.; Mattson, K.; Giaccone, G.; van Zandwijk, N.; Planteydt, H.T.; Kirkpatrick, A.; Dalesio, O. 1991: Mitoxantrone in malignant pleural mesothelioma: a study by the EORTC Lung Cancer Cooperative Group European Journal of Cancer 27(12): 1627-1629
Bassan, R.; Raimondi, R.; Lerede, T.; D'emilio, A.; Buelli, M.; Borleri, G.; Personeni, A.; Bellavita, P.; Rodeghiero, F.; Barbui, T. 1998: Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia Haematologica 83(7): 627-635
Harousseau, J.L.; Pignon, B.; Cahn, J.Y. 1993: Comparison between bone marrow autograft and intensive chemotherapy as treatment for maintenance of complete remission in acute myeloblastic leukemia in the adult. GOELAM Group Nouvelle Revue Francaise d'Hematologie 35(3): 197-198
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Watanabe, R.; Murata, M.; Takayama, N.; Tokuhira, M.; Kizaki, M.; Okamoto, S.; Kawai, Y.; Watanabe, K.; Murakami, H.; Kikuchi, M.; Nakamura, S.; Ikeda, Y. 1997: Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS) Thrombosis and Haemostasis 77(4): 641-645
Bassan, R.; Barbui, T. 1995: Remission induction therapy for adults with acute myelogenous leukemia: towards the ICE age? Haematologica 80(1): 82-90
Udén, A.M.; Palmblad, J.; Venizelos, N. 1982: Neutrophil function during immunotherapy for acute myelogenous leukemia in remission Nouvelle Revue Francaise d'Hematologie 24(4): 231-235
Piccaluga, P.Paolo.; Martinelli, G.; Malagola, M.; Rondoni, M.; Bianchini, M.; Visani, G.; Baccarani, M. 2003: Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature Haematologica 88(8): Ecr28